Poster Abstract Session:
259. Viral Infections in Transplantation
Saturday, October 7, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD

Multiplex Detection of DNA Viruses in Transplant Recipients
Susanna K. Tan, MD; Peidong Shen, PhD; Martina I. Lefterova, MD, PhD; Malaya K. Sahoo, PhD; Justin Odegaard, MD, PhD; Benjamin Pinsky, MD, PhD; Curt Scharfe, MD, PhD
Danger of Biologic Therapy with Unrecognized Human T-cell Lymphotrophic Virus 1 (HTLV-1)
Seth Howell, MS-IV; Marlon Rampaul, MBBS; Divya Ahuja, MD; Joseph Horvath, MD
  • HTLV-1.pdf (771.2 kB)
  • Epstein-Barr viral load monitoring for diagnosing posttransplant lymphoproliferative disorder in paediatric liver and heart transplant recipients
    Euri Seo, M.D; Joonil Kim, M.D; Jina Lee, M.D, Ph.D; Seak Hee Oh, M.D; Kyung Mo Kim, M.D; Dae Yeon Kim, M.D; Young-Hee Kim, M.D
  • ebv.pdf (394.2 kB)
  • Renal Dysfunction in a Cohort of Renal Transplant Recipients: Impact of BK Polyomavirus
    Álvaro H Borges, MD, MSc, PhD; Alessandro Cozzi-Lepri, PhD; Hans H. Hirsch, MD, MSc; Caspar Da Cunha-Bang, MD; Neval Ete Wareham, MD; Casper Møller Frederiksen, MSc, PhD; Amanda Mocroft, MSc, Professor; Jens Lundgren, MD, DMSc, Professor; Søren Schwartz Sørensen, MD
  • Poster_IDWeek_BK virus.pdf (284.6 kB)
  • Five-Year Experience with Ganciclovir Resistant Cytomegalovirus in Renal Transplant Recipients at a Single Academic Center
    Adam Baghban, MD; Marwan M. Azar, MD; Marie Landry, MD, FIDSA; Maricar Malinis, MD, FACP, FIDSA
  • cmv.pdf (462.4 kB)
  • Cytomegalovirus (CMV) associated health care utilization in unmodified and ex-vivo T-cell depleted hematopoietic stem cell transplantation (HCT).
    Yao-Ting Huang, PhD, MPH; Seong Jin Kim, MPH; Paige Nichols, BA; Daniel Burack, BA; Miguel-Angel Perales, MD; Genovefa Papanicolaou, MD
  • Poster2437Revised2.pdf (182.7 kB)
  • Respiratory syncytial virus in Hematopoietic Stem Cell Transplantation- Risk Stratification and Outcomes
    Hashim Abbas, MBBS, MD; Lisa Rybicki, MS; Donna Abounader, Research supervisor; Sherif Mossad, MD, FIDSA; Navneet Majhail, MD, MS; Eric Cober, MD
    Clinical outcomes in HIV+/HCV+ co-infected kidney transplant recipients in the pre- and post-direct acting antiviral (DAA) therapy eras: 10 year single center experience.
    Shweta Anjan, MD; Jose F. Camargo, MD; Michele I Morris, MD, FIDSA, FAST; Lilian M. Abbo, MD; Jacques Simkins, MD; Gisele Guerra, MD; Warren Kupin, MD; Adela Mattiazzi, MD; Linda Chen, MD; George Burke, MD; Jose Figueiro, MD; Phillip Ruiz, MD; Kalyan Bhamidimarri, MD; David Roth, MD
    Impact of CMV Blips in Transplant Recipients
    Isabelle Paula Lodding, MD; Amanda Mocroft, MSc, Professor; Caspar Da Cunha Bang, MD, PhD; Finn Gustafsson, MD; Martin Iversen, MD, D.M.Sc.; Nikolai Kirkby, MSc; Michael Perch, MD; Allan Rasmussen, MD; Henrik Sengeløv, MD; Søren Schwartz Sørensen, MD; Jens Lundgren, MD, DMSc, Professor
    BK polyoma virus nephropathy in hematopoietic cell transplant recipients with renal dysfunction
    Yeon Joo Lee, MD, MPH; Ilya Glezerman, MD; Ann Jakubowski, MD, PhD; Genovefa Papanicolaou, MD
    Coronavirus Infection in Hematopoietic Stem Cell Transplant Recipients
    Emily Eichenberger, MD; Michael Satlin, MD; Dana Zappetti, MD; Catherine Small, MD; Tsiporah Shore, MD; Koen Van Besien, MD, PhD; Rosemary Soave, MD, FIDSA
    Respiratory Viral Infections in Multiple Myeloma Patients
    Mary J Burgess, MD; Meera Mohan, MD; Juan Carlos Rico Crescencio, MD; Frankie Wolfe, RN, CIC; William Bellamy, PhD; Atul Kothari, MD
    Clinical features and outcomes of immunocompromised adults hospitalized with laboratory-confirmed influenza in the United States, 2011–2015
    Jennifer Collins, MD; Kyle Openo, MPH; Monica Farley, MD, FIDSA; Charisse Nitura Cummings, MPH; Patricia Ryan, MS; Kimberly Yousey-Hines, MPH, CPH; Elizabeth Dufort, MD; Ruth Lynfield, MD, FIDSA; Krista Lung, MPH; Ann Thomas, MD, MPH; Nisha Alden, MPH; Pam D. Kirley, MPH; Seth Eckel, MPH; Nancy M. Bennett, MD; William Schaffner, MD, FIDSA, FSHEA; Mary Louise Lindegren, MD, MPH; Mary Hill, MPH; Joan Baumbach, MD, MPH, MS; Angela P. Campbell, MD, MPH, FPIDS, FIDSA; Shikha Garg, MD, MPH; Evan J. Anderson, MD
    Incidence and Outcomes of Cytomegalovirus (CMV) Infection among Hematopoietic Stem Cell Transplant (HSCT) Recipients
    Jon P. Furuno, PhD; Miriam R. Elman, MPH, MS; Brie N. Noble, BS; Lynne Strasfeld, MD; Gregory B. Tallman, PharmD; Jessina C. McGregor, PhD
  • CMV_IDWeek2017_Poster_Final.pdf (136.0 kB)
  • Risk factors for development of cytomegalovirus resistance in solid organ transplantation: a retrospective nested case control study
    Uriel Sandkovsky, MD, MS, FACP; Fang Qiu, MS; Andre C. Kalil, MD, MPH, FIDSA; Ada Florescu, BS; Natasha Wilson, RN; Christa Manning, BS; Diana F. Florescu, MD
  • CMV IDSA.pdf (1.0 MB)
  • Changes in the CD4+ T cell phenotypes may contribute to CD8+ T cell exhaustion in chronic EBV high viral load pediatric solid organ transplant patients. 
    Masaki Yamada, MD; Camila Macedo, MD; Paul Fadakar, MD; Marian Michaels, MD, MPH; Micahel Green, MD, MPH; Nguyen Christina, MD; Brian Feingold, MD, MS; George V. Mazariegos, MD; Diana Metes, MD
  • 2017-10-04 2449 MYAMADA.pdf (3.0 MB)
  • Lymphopenia: a novel predictor for recurrent cytomegalovirus disease in solid organ transplant recipients
    Bradley Gardiner, MBBS; Natalie Nierenberg, MD, MPH; Jennifer Chow, MD, MS; Robin Ruthazer, MPH; David Kent, MD; David Snydman, MD, FIDSA
    Genetic Diversity of Epstein - Barr Virus Lytic Gene BZLF-1 among Patients with and without Post-transplant Lymphoproliferative Disorder
    Upton Allen, MD, FIDSA; Marianna Abdulnoor, BSc (Candidate); Nasser Khodai-Booran, PhD; Tara Paton, PhD; Anne Dipchand, MD; Diane Hebert, MD; Vicky Ng, MD; Melinda Solomon, MD

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.